Elysium Therapeutics
PrivateLast Round
SAFE
Jan 28, 2026
Total Funding Raised
$11.49M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Elysium Therapeutics operates in Healthcare & Life Sciences and is based in Lyons, Colorado. Its latest recorded funding round was a SAFE round in January 2026.
Elysium Therapeutics is a biopharmaceutical company developing treatments to rescue and reverse overdoses caused by oral synthetic opioids, such as fentanyl.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elysium Therapeutics Comparables
Compare Elysium Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Consegna Pharma Inc. | 87% | |
| CounterX Therapeutics | 78% | |
| Cessation Therapeutics | 78% |
For institutional investors. Book with your work email.
Elysium Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Jan 28, 2026 | ||||
| Seed | Dec 20, 2017 | ||||
| Grant | Dec 7, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Elysium Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ohio Third Frontier | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 144% MoM.
- Jun 18, 2026
Monthly visitors increased 225% MoM.
For institutional investors. Book with your work email.
Elysium Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elysium Therapeutics's valuation, stock price, and market status.
Is Elysium Therapeutics a public or private company?
Elysium Therapeutics is a private company.
What is the current stock price of Elysium Therapeutics?
Elysium Therapeutics is a private company, so its shares have no public market price. Caplight tracks Elysium Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elysium Therapeutics worth (valuation)?
Valuation information for Elysium Therapeutics is not publicly available.
Can I buy Elysium Therapeutics stock?
Elysium Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elysium Therapeutics's last funding round?
Elysium Therapeutics's most recent funding round was SAFE on January 28, 2026.
Who are the main investors in Elysium Therapeutics?
Key investors in Elysium Therapeutics include Ohio Third Frontier.
Will Elysium Therapeutics IPO soon?
No public IPO plans have been announced for Elysium Therapeutics.
How can I track Elysium Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Elysium Therapeutics's shares on secondary markets.